RU2019125177A - Новые производные амино-имидазопиридина в качестве ингибиторов янус-киназы и их фармацевтическое применение - Google Patents

Новые производные амино-имидазопиридина в качестве ингибиторов янус-киназы и их фармацевтическое применение Download PDF

Info

Publication number
RU2019125177A
RU2019125177A RU2019125177A RU2019125177A RU2019125177A RU 2019125177 A RU2019125177 A RU 2019125177A RU 2019125177 A RU2019125177 A RU 2019125177A RU 2019125177 A RU2019125177 A RU 2019125177A RU 2019125177 A RU2019125177 A RU 2019125177A
Authority
RU
Russia
Prior art keywords
acetonitrile
cyclohexyl
imidazo
pyridin
hydroxyethyl
Prior art date
Application number
RU2019125177A
Other languages
English (en)
Russian (ru)
Other versions
RU2019125177A3 (cg-RX-API-DMAC10.html
Inventor
Йенс ЛАРСЕН
Могенс Ларсен
Ларс Кюн РАСМУССЕН
Андреас Ритзен
Тине Марианне ДУУС
Original Assignee
Лео Фарма А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лео Фарма А/С filed Critical Лео Фарма А/С
Publication of RU2019125177A publication Critical patent/RU2019125177A/ru
Publication of RU2019125177A3 publication Critical patent/RU2019125177A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU2019125177A 2017-01-11 2018-01-10 Новые производные амино-имидазопиридина в качестве ингибиторов янус-киназы и их фармацевтическое применение RU2019125177A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17151020 2017-01-11
EP17151020.9 2017-01-11
PCT/EP2018/050548 WO2018130563A1 (en) 2017-01-11 2018-01-10 Novel amino-imidazopyridine derivatives as janus kinase inhibitors and pharmaceutical use thereof

Publications (2)

Publication Number Publication Date
RU2019125177A true RU2019125177A (ru) 2021-02-15
RU2019125177A3 RU2019125177A3 (cg-RX-API-DMAC10.html) 2021-05-11

Family

ID=57777557

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019125177A RU2019125177A (ru) 2017-01-11 2018-01-10 Новые производные амино-имидазопиридина в качестве ингибиторов янус-киназы и их фармацевтическое применение

Country Status (25)

Country Link
US (1) US10703751B2 (cg-RX-API-DMAC10.html)
EP (1) EP3568396B1 (cg-RX-API-DMAC10.html)
JP (1) JP7009504B2 (cg-RX-API-DMAC10.html)
KR (1) KR102548543B1 (cg-RX-API-DMAC10.html)
CN (1) CN110167938B (cg-RX-API-DMAC10.html)
AU (1) AU2018208516B2 (cg-RX-API-DMAC10.html)
CA (1) CA3045567A1 (cg-RX-API-DMAC10.html)
CY (1) CY1123864T1 (cg-RX-API-DMAC10.html)
DK (1) DK3568396T3 (cg-RX-API-DMAC10.html)
ES (1) ES2846741T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20210095T1 (cg-RX-API-DMAC10.html)
HU (1) HUE052720T2 (cg-RX-API-DMAC10.html)
IL (1) IL267829B (cg-RX-API-DMAC10.html)
LT (1) LT3568396T (cg-RX-API-DMAC10.html)
MX (1) MX389378B (cg-RX-API-DMAC10.html)
MY (1) MY195576A (cg-RX-API-DMAC10.html)
PL (1) PL3568396T3 (cg-RX-API-DMAC10.html)
PT (1) PT3568396T (cg-RX-API-DMAC10.html)
RS (1) RS61317B1 (cg-RX-API-DMAC10.html)
RU (1) RU2019125177A (cg-RX-API-DMAC10.html)
SI (1) SI3568396T1 (cg-RX-API-DMAC10.html)
TW (1) TWI760419B (cg-RX-API-DMAC10.html)
UA (1) UA123972C2 (cg-RX-API-DMAC10.html)
WO (1) WO2018130563A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201904190B (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
MX2022004474A (es) 2016-12-16 2023-08-15 Janssen Pharmaceutica Nv Inhibidores de moléculas pequeñas de la familia de quinasas jak.
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Jak激酶家族之小分子抑制劑
WO2020007698A1 (en) * 2018-07-06 2020-01-09 Leo Pharma A/S Novel amino-imidazopyrimidine derivatives as janus kinase inhibitors and pharmaceutical use thereof
JP7345220B2 (ja) * 2019-08-30 2023-09-15 ティーエスディー ライフ サイエンス カンパニー リミテッド イミダゾピリジン誘導体及びこれを有効成分として含有する薬学的組成物
US12390451B2 (en) 2021-03-11 2025-08-19 Janssen Pharmaceutica Nv Small molecule inhibitor of the JAK family of kinases
CN119569971B (zh) * 2025-02-07 2025-05-27 吉林大学 一种用于蛋白质磷酸化和棕榈酰化修饰同时筛选的Janus材料的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009100375A1 (en) * 2008-02-06 2009-08-13 Bristol-Myers Squibb Company Substituted imidazopyridazines useful as kinase inhibitors
CN102712640A (zh) 2010-01-12 2012-10-03 弗·哈夫曼-拉罗切有限公司 三环杂环化合物、其组合物和应用方法
SG10201505997TA (en) * 2010-08-05 2015-09-29 Amgen Inc Benzimidazole And Azabenzimidazole Compounds That Inhibit Anaplastic Lymphoma Kinase
EP2518071A1 (en) 2011-04-29 2012-10-31 Almirall, S.A. Imidazopyridine derivatives as PI3K inhibitors
EP2527344A1 (en) 2011-05-25 2012-11-28 Almirall, S.A. Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
WO2013007768A1 (en) 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Tricyclic heterocyclic compounds, compositions and methods of use thereof as jak inhibitors
WO2013007765A1 (en) 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Fused tricyclic compounds for use as inhibitors of janus kinases
UY34616A (es) 2012-02-10 2013-09-30 Galapagos Nv Nuevo compuesto útil para el tratamiento de enfermedades degenerativas e inflamatorias.
CA2888816A1 (en) 2012-11-01 2014-05-08 Incyte Corporation Tricyclic fused thiophene derivatives as jak inhibitors
EP3181564B1 (en) * 2012-11-20 2019-09-18 H. Hoffnabb-La Roche Ag Aminopyrimidine compounds as inhibitors of t790m containing egfr mutants
CN104098563A (zh) 2013-04-02 2014-10-15 山东亨利医药科技有限责任公司 Jnk抑制剂化合物
SG11201609016VA (en) 2014-04-30 2016-11-29 Incyte Corp Processes of preparing a jak1 inhibitor and new forms thereto
EA201990523A1 (ru) 2016-10-03 2019-10-31 НОВЫЕ СЕЛЕКТИВНЫЕ ИНГИБИТОРЫ Jak1 И ИХ ПРИМЕНЕНИЕ
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز

Also Published As

Publication number Publication date
NZ754922A (en) 2025-11-28
CA3045567A1 (en) 2018-07-19
JP2020504186A (ja) 2020-02-06
TWI760419B (zh) 2022-04-11
CN110167938A (zh) 2019-08-23
BR112019014191A2 (pt) 2020-02-11
IL267829A (en) 2019-09-26
HRP20210095T1 (hr) 2021-03-05
MX389378B (es) 2025-03-20
ES2846741T3 (es) 2021-07-29
MY195576A (en) 2023-02-02
PL3568396T3 (pl) 2021-05-31
US20190367512A1 (en) 2019-12-05
DK3568396T3 (da) 2021-01-18
WO2018130563A1 (en) 2018-07-19
EP3568396A1 (en) 2019-11-20
KR102548543B1 (ko) 2023-06-29
PT3568396T (pt) 2021-02-09
AU2018208516B2 (en) 2021-07-08
LT3568396T (lt) 2021-02-10
CY1123864T1 (el) 2022-05-27
TW201829407A (zh) 2018-08-16
IL267829B (en) 2022-02-01
US10703751B2 (en) 2020-07-07
EP3568396B1 (en) 2020-11-11
ZA201904190B (en) 2020-10-28
RU2019125177A3 (cg-RX-API-DMAC10.html) 2021-05-11
KR20190103231A (ko) 2019-09-04
SI3568396T1 (sl) 2021-04-30
RS61317B1 (sr) 2021-02-26
HUE052720T2 (hu) 2021-05-28
JP7009504B2 (ja) 2022-01-25
AU2018208516A1 (en) 2019-07-11
CN110167938B (zh) 2024-06-14
MX2019008331A (es) 2020-01-14
UA123972C2 (uk) 2021-06-30

Similar Documents

Publication Publication Date Title
CN105492439B (zh) 作为溴结构域抑制剂的取代的双环化合物
RU2744897C2 (ru) Гетероциклические соединения и их применение
CN105407888B (zh) 新双环溴结构域抑制剂
JP6952695B2 (ja) インフルエンザウイルス複製の阻害剤、その適用方法および使用
RU2470642C2 (ru) Аналоги птерина для лечения состояния, чувствительного к вн4
US20140357636A1 (en) Treatment of Skeletal-Related Disorders
US8691777B2 (en) Combination therapy
JP2015536973A (ja) PDE4阻害剤とPI3δ阻害剤または二重PI3δ−γキナーゼ阻害剤とを含有する薬学的組成物
JP2023506787A (ja) Parp阻害薬と組み合わせたatr阻害薬の使用
US20030022898A1 (en) Methods of treating inflammatory and immune diseases using inhibitors of IkappaB kinase (IKK)
JP2020504186A5 (cg-RX-API-DMAC10.html)
HRP20210095T1 (hr) Novi derivati amino-imidazopiridina kao inhibitori janus kinaze i njihova farmaceutska upotreba
CA3176191A1 (en) Treatment of proliferative diseases of the cns
EP1363993A2 (en) METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF I$g(k)B KINASE (IKK)
JP2011518168A5 (cg-RX-API-DMAC10.html)
CA3237156A1 (en) Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treating medical conditions
CN109476600A (zh) 吡啶硫酮、其药物组合物及其用于治疗增殖性、炎症性、神经变性或免疫-介导的疾病的治疗用途
Radziwill et al. Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: an open-label study
RU2018130097A (ru) Лечение экземы кистей
JP2014527997A5 (cg-RX-API-DMAC10.html)
KR102128866B1 (ko) 오로라 키나제 저해제를 사용하는 암 치료 방법
RU2018114922A (ru) Лечение очаговой алопеции
JP2005507411A (ja) 下肢静止不能症候群の治療における、ニコチン性アセチルコリン受容体アゴニスト。
RU2013149635A (ru) Соединения солифенацина и слюнные стимулянты для лечения гиперактивности мочевого пузыря
JP2021528479A5 (cg-RX-API-DMAC10.html)